Jim Tananbaum has a unique perspective on the financial industry thanks to his hard hitting work as the CEO for Foresite Capital. Tananbaum has been one of the most innovative investors we have seen over the past several years and his ability to fundamentally work the market has made him a legend to his clients. Tananbaum’s extensive experience is definitely worth digging deeper into and fortunately for us he is open about his work and experience.
When talking with Jim Tananbaum you can see right away that he has focused entirely on cultivating his work with Foresite Capital. Foresite has been in the business for over 25 years, working primarily with healthcare. Tananbaum claims that, for him, the reason he has found so much success is simple and that it largely exists due to the innovative teams he has managed to cultivate over the years. Above all, still, Tananbaum credits his understanding of healthcare. Tananbaum says, “To me, Foresite truly means to understand and harness healthcare’s future.”
To date Foresite has invested in 77 healthcare companies that focus in a slew of different specialties: medical services, genome sequencing, biopharmaceuticals and more. Being this heavily invested in so many different companies means that Tananbaum needs to work hard to keep ahead of the pack. Let’s dig into what a typical day for the CEO of Foresite Capital could look like.
Jim Tananbaum starts each and every day like the one before it: closely working with his team members by way of in person meetings and networked phone calls. Tananbaum works through presentations, meetings, and company updates before finally retiring to his home to be with his family. Tananbaum says, “Family is my highest priority and one of my favorite activities is having dinner with them.” Visit Medium for more details.
Finding success as an entrepreneur or as an investor can take some work, and it means always pushing for that next concept. Foresite finds success thanks in large part to Tananbaum’s insistence on hiring and working with the smartest, most active, and persistent leaders within the healthcare industry. So far so good and it looks like Jim Tananbaum still has plenty left to do.
Read more: https://ideamensch.com/jim-tananbaum/
AviWeisfogel is the founder and owner of Dental Sleep Masters. This is a company that that he founded in 2014 that teaches dentists how to treat sleep related disorders such as sleep apnea through the use of oral appliances. Dr. Weisfogel also founded Unlimited Sleep Patient in 2012. This company educated dentists on how to diagnose and recognize sleep related illnesses in their patients. It also taught them how to better serve patients afflicted with a sleep disorder and how to increase revenue serving such patients at their practice.
Yet another sleep disorder treatment business that AviWeisfogel established is called Healthy Heart Sleep. This company provided consulting service on the creation and management of sleep labs. These are practices designed to address the needs of patients who have sleep related disorders.
Before getting involved in the business of treating, managing and educating others about sleep related illnesses, Dr. AviWeisfogel was a dentist for over a decade. He had his own dental practice called Old Bridge Dental Care in Old Bridge, New Jersey. AviWeisfogel is a certified dentist with a doctorate dental surgery from the New York University College of Dentistry. He also holds a bachelorsdegree in biology and psychology.
Some Highlights OnAviWeisfogel’s Interview On Ideamensch
Ideamensch began the interview by asking AviWeisfogel where he got the idea to start his current business called Dental Sleep Masters. Avi’s response was that he was always fascinated sleep medicine. He combined his medical knowledge along with his marketing knowledge and found that he could tap into a niche market that no one had before him for more info: https://www.bizjournals.com/newyork/potmsearch/detail/submission/6417534 click here.
The next question given to AviWeisfogel was how a typical day unfolds for him on the job. Dr. Weisfogel responded by saying that he begins his day with a prayer and then talks to his his life coach. All of this is done before he begins his workday which lasts from 8 A.M. to 7 P.M. During that time he is busy with calls, meetings and working with team members. AviWeisfogel says that he writes almost everything down to keep himself motivated and organized.
USHEALTH Advisors is a national health insurance company that sells individual health coverage and additional health plans which help individuals and families with their care.USHEALTH Advisors is also a wholly owned subsidiary of USHEALTH Group.Which specializes in individual and family health care whom either have suffered by their illness,experienced a short term accident disability and/or whom require vision and or more services.USHEALTH Advisors since it’s inception has provided unparalleled excellence in its service to its customers.Offering affordable health insurance not seen in the industry today.
USHEALTH Advisors is BBB accredited since 2013 and has been in business for 57 years. USHEALTH Advisors started locally on 02/01/1984 and has a 4.51 out of 5 stars as provided by the BBB.
The average salary for a USHEALTH Advisor is,
• Account Manager $52,078
• Insurance Agent $70,038
• Insurance Agent-Contractor $78,044
• Insurance Sales Agent $43,667
The address for USHEALTH Advisors is 2563 SW Grapevine Pkwy,Grapevine,TX 76051 and the number to contact is
(HOPE) is the motto that USHEALTH Advisors lives by.It stands for Helping Other People Everyday.A saying that all of our Advisors demonstrate on a daily basis.
In order to login, you must go to http://www.ushacareers.com/
USHEALTH Advisors will go the distance in your healthcare provide you with the utmost respect when it comes to your care. Trust on USHEALTH Advisors to go the extra mile.No matter what comes your way.
Recently, DR. Rocklage was celebrated for contributing towards the renovation of Moungi Bawendi’s nanochemistry and nanotechnology lab space. He pursued his PhD studies at MIT Department of Chemistry under Professor Richard R. Schrock, the Nobel Prize Winner in chemistry. When the former head of the Chemistry Department approached Scott about the possibility of supporting the projects in the department, he immediately responded by asking about the most urgent need. His willingness to support MIT is a gratitude for giving him the platform to nurture his professional life and career in chemistry. Scott and his wife visited the department to celebrate the milestone.
After exploring the newly renovated lab space offered by Professor Bawendi and his two graduate students, He Wei and Whitney Hess, Bawendi group members and faculty converged at the lab’s vestibule to view the display of a plaque honoring the Rocklages. Timothy Jamison, the current Department Head, Sylvia Ceyer and Professor Moungi Bawendi paid their tribute to the Rocklages. The department’s 2010 newsletter featured Scott Rocklage as an alumnus profile where he said that he never knew his survivalist skills would be of great importance to MIT. He posited that he was lucky to be accepted in the department where he had a chance to associate with individuals having big intellects and visions. Scott attributed his success to the productive atmosphere of high competition, reagent, glove box time and Dick’s leadership. Scott also thanked his friends Howard Turner, Clayton Wood and Jere Fellman for their support while studying at MIT.
About Scott Rocklage
Scott Rocklage is a managing partner at 5AM Ventures, a company that he joined as a venture partner in 2003. He has over two decades of experience in the healthcare management industry. Over the years, Scott has provided transformative leadership to different organization. His engagement with different stakeholders has earned him extensive knowledge in healthcare. Through networking, Scott was able to obtain FDA approval of the three US new drugs, which are Omniscan™, Teslascan® and Cubicin® and entered six drug candidates into clinical trials.
His broad involvement in the healthcare management field saw him serve as the president and CEO of Nycomed Salutar. He has also worked as the chairman and CEO of Cubist Pharmaceuticals. In addition, Scott has been the president, chairman and CEO of Nycomed Interventional. He also assumed various R&D positions at Salutar and Catalyca. Scott heads the Board of Achaogen, Semprus and Relypsa. Owing to his extensive knowledge, different companies have enlisted his services. Scott is an active member of the board of WaveRx, board of associates at the Whitehead Institute, as well as Pulmatrix and Variation. He is an alumnus of the University of California, Berkley, and the Massachusetts Institute of Technology where he graduated with a B.S. and a PhD in Chemistry respectively.